Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

This grant supports discovery and early evaluation of strong candidate biomarkers or biomarker signatures for neurological and neuromuscular disorders. It funds work that identifies and conducts initial biological, analytical, and clinical assessment of these markers, including animal studies and preliminary human evaluation with standardized samples or datasets, aiming to produce candidates ready for definitive validation.